UKALL X--an effective treatment for stage III mediastinal non-Hodgkin's lymphoma.
Open Access
- 1 March 1990
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 65 (3) , 252-254
- https://doi.org/10.1136/adc.65.3.252
Abstract
Fifteen children with mediastinal non-Hodgkin's lymphoma were treated with MRC UKALL X, the current national protocol for acute lymphoblastic leukaemia. The treatment was well tolerated, and in a minimum follow up period of 46 months the event free survival of 93% was significantly better than that in a group of historical controls treated with intermittent chemotherapy regimens whose survival was only 57%. We conclude that intensive induction and consolidation treatment, with continued oral drugs, provides an effective approach to the management of mediastinal non-Hodgkin's lymphoma.This publication has 7 references indexed in Scilit:
- Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).Archives of Disease in Childhood, 1987
- A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabineBlood, 1985
- A NOVEL TREATMENT OF CHILDHOOD LYMPHOBLASTIC NON-HODGKINS LYMPHOMA - EARLY AND INTERMITTENT USE OF TENIPOSIDE PLUS CYTARABINE1985
- Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG)British Journal of Cancer, 1984
- Childhood Non-Hodgkin's LymphomaNew England Journal of Medicine, 1983
- Non-Hodgkin's lymphoma in children.A progress report on the original patients treated with the LSA2-L2 protocolCancer, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977